Search
Menu
Lambda Research Optics, Inc. - Limited Time Offer

Bio-Rad Levels Charges Against Zeiss

Facebook X LinkedIn Email
A dispute over rights to multiphoton fluorescence excitation has emerged between Carl Zeiss GmbH of Jena, Germany, and Bio-Rad Laboratories Inc. in Hertfordshire, UK. Bio-Rad says it signed a worldwide exclusive license with Cornell University's research foundation in 1996 to commercialize and market the technology. Since then, it has worked with the Ithaca, N.Y., university to develop the technology.Read full article

Related content from Photonics Media



    Articles


    Webinars


    Photonics Dictionary Terms


    Media
    Published: September 1999
    Businesslight speed

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.